Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-03-20Clinical Trial Update: Study of Low-Dose Intravenous Decitabine in Patients Aged > 60 Years With Acute Myeloid Leukemia [Phase 2]
This update reports on a Phase 2 trial evaluating low-dose intravenous decitabine in patients aged over 60 with acute myeloid leukemia. The …
-
CLINICAL_TRIALS trial_result · 2009-02-24Clinical Trial Update: Treatment of Non Promyelocytic Acute Myeloid Leukaemia on Elderly Patients by Low Dose Cytosar Plus Arsenic Trioxide [Phase 2]
Phase 2 clinical trial evaluating low-dose cytarabine (Cytosar) in combination with arsenic trioxide for elderly patients with non-promyeloc…
-
CLINICAL_TRIALS trial_result · 2009-02-13Clinical Trial Update: Haploidentical Stem Cell Transplant for Treatment Refractory Hematological Malignancies [Phase 2]
A Phase 2 clinical trial from St. Jude evaluated haploidentical hematopoietic stem cell transplantation for treatment-refractory hematologic…
-
CLINICAL_TRIALS trial_result · 2009-02-09Clinical Trial Update: Risk-Adapted Therapy of Acute Myeloid Leukemia of Adults (18-60 Years) According to the Cytogenetic Result [Phase 3]
Phase 3 study evaluating risk-adapted therapy for adults with acute myeloid leukemia (ages 18-60) based on cytogenetic risk; the trial statu…
-
CLINICAL_TRIALS trial_result · 2009-02-02Clinical Trial Update: High-Dose Imatinib for Relapsed/Refractory c-Kit Positive Acute Myelogenous Leukemia (AML) [Phase 2]
This document reports the completion of a Phase 2 trial evaluating high-dose Imatinib in relapsed or refractory c-Kit–positive acute myeloid…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-01-29Clinical Trial Update: Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies [Phase 3]
This document reports a Phase 3 clinical trial evaluating haploidentical hematopoietic stem cell transplantation in patients with hematologi…
-
CLINICAL_TRIALS trial_result · 2009-01-29Clinical Trial Update: Stem Cell Transplantation for Patients With Hematologic Malignancies [Phase 3]
A Phase 3 clinical trial evaluating stem cell transplantation for hematologic malignancies has completed. The study covered several conditio…
-
CLINICAL_TRIALS trial_result · 2009-01-29Clinical Trial Update: Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies [Phase 2]
Phase 2 clinical trial update on stem cell transplantation as immunotherapy for hematologic malignancies. The trial status is completed.
-
CLINICAL_TRIALS trial_result · 2009-01-29Clinical Trial Update: Study Evaluating the Addition of Amifostine (Ethyol®) to Idarubicin and Cytosine Arabinoside in Older Patients With Acute Myeloid Leukemia [Phase 1, Phase 2]
Clinical trial evaluating amifostine added to standard idarubicin and cytarabine therapy in older adults with acute myeloid leukemia; the Ph…
-
CLINICAL_TRIALS trial_result · 2009-01-26Clinical Trial Update: Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCT [Phase 2]
A Phase II trial evaluating busulfan and fludarabine as preparative conditioning therapy in adults with hematopoietic disorders undergoing m…
-
CLINICAL_TRIALS trial_result · 2009-01-12Clinical Trial Update: Induction With or Without Granulocyte Colony-Stimulating Factor in AML Transplantation in AML [Phase 3]
A Phase 3 trial evaluating induction with or without granulocyte colony-stimulating factor in AML transplantation has completed.
-
CLINICAL_TRIALS trial_result · 2008-12-30Clinical Trial Update: Feasibility and Efficacy Study of Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) With Fludarabine, Busulfan, and Total Body Irradiation (TBI) [Phase 2]
Phase 2 feasibility and efficacy study of a conditioning regimen using fludarabine, busulfan, and total body irradiation before allogeneic h…
-
CLINICAL_TRIALS trial_result · 2008-11-19Clinical Trial Update: SMD_FLAG-IDA_98: FLAG-IDA in Induction Treatment of High Risk Myelodysplastic Syndromes or Secondary Acute Myeloblastic Leukemia [Phase 4]
Phase 4 trial evaluating FLAG-IDA induction therapy for high-risk myelodysplastic syndromes or secondary acute myeloid leukemia has complete…
-
CLINICAL_TRIALS trial_result · 2008-11-18Clinical Trial Update: Fludarabine, Cytarabine, Topotecan in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 4]
A Phase 4 trial evaluated a three-drug regimen (fludarabine, cytarabine, and topotecan) in patients with relapsed or refractory acute myeloi…
-
CLINICAL_TRIALS trial_result · 2008-08-06Clinical Trial Update: Trial With Azacitidine in Newly Diagnosed Acute Myelogenous Leukemia (AML) Veterans Administration (VA) Elderly Patients Not Eligible for Standard Induction Therapy [Phase 2]
Phase 2 clinical trial evaluating azacitidine in newly diagnosed acute myeloid leukemia patients who are elderly and not eligible for standa…
-
CLINICAL_TRIALS trial_result · 2008-07-18Clinical Trial Update: Lentivirus Transduced Acute Myeloid Leukaemia Blasts Expressing B7.1 (CD80) and IL-2 [Phase 1]
Phase 1 clinical trial of lentivirus-transduced acute myeloid leukemia blasts engineered to express CD80 and IL-2. The study is sponsored by…
-
CLINICAL_TRIALS trial_result · 2008-06-18Clinical Trial Update: Treatment Outcome in Elderly Patients [Phase 3]
A Phase 3 clinical trial evaluating treatment outcomes in elderly patients with acute myeloid leukemia has completed. The provided snippet d…
-
CLINICAL_TRIALS trial_result · 2008-04-28Clinical Trial Update: Autologous Bone Marrow Transplant for Children With Acute Myelogenous Leukemia (AML) in First Complete Remission [Phase 1]
Phase 1 trial completed evaluating autologous bone marrow transplantation as consolidation therapy in children with Acute Myeloid Leukemia i…
-
CLINICAL_TRIALS trial_result · 2008-04-01Clinical Trial Update: Zosuquidar in Combination With Daunorubicin and Cytarabine in Patients Ages 55-75 With Newly Diagnosed Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]
This update reports on a completed Phase 1/2 trial evaluating Zosuquidar in combination with daunorubicin and cytarabine in adults aged 55-7…
-
CLINICAL_TRIALS trial_result · 2008-04-01Clinical Trial Update: A Trial of Gemtuzumab Ozogamicin (GO) in Combination With Zosuquidar in Patients With CD33 Positive Acute Myeloid Leukemia [Phase 1, Phase 2]
A Phase 1/2 study evaluating gemtuzumab ozogamicin in combination with zosuquidar for CD33-positive acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2008-02-21Clinical Trial Update: A Randomized Study of Post-Remission Therapy in Elderly Patients With Acute Myelogenous Leukemia. [Phase 3]
This document reports the termination of a Phase 3 randomized trial evaluating post-remission therapy in elderly patients with Acute Myeloid…
-
CLINICAL_TRIALS trial_result · 2008-02-11Clinical Trial Update: MLN518 in Combination With Standard Induction Chemo. for Treatment of Patients With Newly Diagnosed Acute Myelogenous Leukemia [Phase 1]
This Phase 1 trial evaluated MLN518 in combination with standard induction chemotherapy in patients with newly diagnosed acute myeloid leuke…
-
CLINICAL_TRIALS trial_result · 2008-02-08Clinical Trial Update: Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family Donor [Phase 2]
Phase 2 clinical trial evaluating tacrolimus and mycophenolate mofetil as post-grafting immunosuppression after conditioning with Flu TBI in…
-
CLINICAL_TRIALS trial_result · 2008-01-17Clinical Trial Update: Study of Troxatyl™ Administered by Continuous Infusion to Subjects With Refractory Acute Myelogenous Leukemia (AML) [Phase 1, Phase 2]
A Phase 1/2 trial of Troxatyl given by continuous infusion in subjects with refractory acute myeloid leukemia has been terminated.
-
CLINICAL_TRIALS trial_result · 2008-01-09Clinical Trial Update: DaunoXome + Ara-C vs Daunorubicin + Ara-C in Elderly AML [Phase 3]
Phase 3 trial comparing DaunoXome plus cytarabine against daunorubicin plus cytarabine in elderly patients with acute myeloid leukemia; stud…